Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP319857.RAWn40zhV0ZS2Y8PPFIBY-9OL-l5Bu7vwjvvAI1S7PucY130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP319857.RAWn40zhV0ZS2Y8PPFIBY-9OL-l5Bu7vwjvvAI1S7PucY130_provenance.
• NP193132.RA-G7W8hol9RzOKflboHqVyEQ01rPaU3Fm_2c1HMmidns130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP193132.RA-G7W8hol9RzOKflboHqVyEQ01rPaU3Fm_2c1HMmidns130_provenance.
• NP388747.RAxOq9qqqpIT_oWBCWaxmIyKjylIDKG8Zpj5ppovK_e6Q130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP388747.RAxOq9qqqpIT_oWBCWaxmIyKjylIDKG8Zpj5ppovK_e6Q130_provenance.
• NP301360.RAKbtfnu7ycBydhrp6OkGxisdUihKkey8EfEFY7ktCrPg130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301360.RAKbtfnu7ycBydhrp6OkGxisdUihKkey8EfEFY7ktCrPg130_provenance.
• NP914185.RAUnHbAvCUkmyLyKE2rHYtXpYVL9uv1sdSCCTktHcckzE130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914185.RAUnHbAvCUkmyLyKE2rHYtXpYVL9uv1sdSCCTktHcckzE130_provenance.
• NP914204.RAYXG6cpSzLgyyzRaYVYuv8aATD-wZmeOK_jkKJjAQTy0130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914204.RAYXG6cpSzLgyyzRaYVYuv8aATD-wZmeOK_jkKJjAQTy0130_provenance.
• NP606189.RAc_rW_0Z4Mp5euKunV4mqqsCZVXm8TznWQ3hxAvfpauI130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606189.RAc_rW_0Z4Mp5euKunV4mqqsCZVXm8TznWQ3hxAvfpauI130_provenance.
• NP781304.RAbrD2IIlB2ceTXD2StrezwvgyZKAUoPGOInQo0IJ-d8g130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781304.RAbrD2IIlB2ceTXD2StrezwvgyZKAUoPGOInQo0IJ-d8g130_provenance.
• NP873053.RAdCwNQ5TnrypltuJWaL422Z1AQckI9cuzU0p0pVAi6PY130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873053.RAdCwNQ5TnrypltuJWaL422Z1AQckI9cuzU0p0pVAi6PY130_provenance.
• NP873355.RAXXcJhT5Q3ZVaVdoDUZ3dHN55IW5IdC7cIv1wkGFoee8130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873355.RAXXcJhT5Q3ZVaVdoDUZ3dHN55IW5IdC7cIv1wkGFoee8130_provenance.
• NP978708.RAbp7H6OdJeBNlqeTMLCtkbNJb6-EgwhitSrNLT8IufIM130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978708.RAbp7H6OdJeBNlqeTMLCtkbNJb6-EgwhitSrNLT8IufIM130_provenance.
• NP1314666.RABT3Y6X5RPYVNHMC3If_F657cnCir5eLaP3F05WOygl8130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314666.RABT3Y6X5RPYVNHMC3If_F657cnCir5eLaP3F05WOygl8130_provenance.
• NP1314669.RACyOIZEymMEiuzsMQoMO6tQc0gkItVM5Q6LUDJL5w-54130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314669.RACyOIZEymMEiuzsMQoMO6tQc0gkItVM5Q6LUDJL5w-54130_provenance.
• NP1314672.RABuiviyZzBepIqqEak4ANb1EkJTWRu5Bj7ci52qhbzy4130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314672.RABuiviyZzBepIqqEak4ANb1EkJTWRu5Bj7ci52qhbzy4130_provenance.
• NP781564.RACLDbxnn3U1eS0v8sBk7S7YQEyk5Wl7uoL7rEBRLvqXk130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781564.RACLDbxnn3U1eS0v8sBk7S7YQEyk5Wl7uoL7rEBRLvqXk130_provenance.
• NP606154.RAtrZ3mW2WFQEU2W1SDfbYAJveqQUJcqxQriFgmyBqV8w130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606154.RAtrZ3mW2WFQEU2W1SDfbYAJveqQUJcqxQriFgmyBqV8w130_provenance.
• NP1314677.RARM-C3bAuKuvpCIx2JOxX4T1YKT_0TaKQuJjnCmRGH7E130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314677.RARM-C3bAuKuvpCIx2JOxX4T1YKT_0TaKQuJjnCmRGH7E130_provenance.
• NP1314681.RAdGaC3Rii-WwT6d2xwiE6HslOron_-1YA5jGkrls3xUo130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314681.RAdGaC3Rii-WwT6d2xwiE6HslOron_-1YA5jGkrls3xUo130_provenance.
• NP1314668.RAu_i2WKHUyNwjj51Uqw1N58f8yEFgvIO3vemC5dOBuMA130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314668.RAu_i2WKHUyNwjj51Uqw1N58f8yEFgvIO3vemC5dOBuMA130_provenance.
• NP1314670.RAjR1ux1MfZv7Gus_w3ks_HXIVLV0-h4tvGIi33ZnCER0130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314670.RAjR1ux1MfZv7Gus_w3ks_HXIVLV0-h4tvGIi33ZnCER0130_provenance.
• NP1314674.RAiV1CFeJLjEZflElNND4GC_3SrqHmHTwPrl2w3Akc0hE130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314674.RAiV1CFeJLjEZflElNND4GC_3SrqHmHTwPrl2w3Akc0hE130_provenance.
• NP1314678.RAvQShoLlCFs0kD48_B_cCIAuZhTwZoY0qpx-fHKVA6VM130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314678.RAvQShoLlCFs0kD48_B_cCIAuZhTwZoY0qpx-fHKVA6VM130_provenance.
• NP1314679.RAl_y4tBZzk1Ih3d3EW6UtCMspYHKa1EU7mSRSehsRUZI130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314679.RAl_y4tBZzk1Ih3d3EW6UtCMspYHKa1EU7mSRSehsRUZI130_provenance.
• NP1314680.RAu1zm9ZhjE0U9LLwrMKnJ93kE-5Ju80wgnTRnFO0V8HI130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314680.RAu1zm9ZhjE0U9LLwrMKnJ93kE-5Ju80wgnTRnFO0V8HI130_provenance.
• NP605856.RA31dJfP-FGriBpQuEyger-YYd7h4-BddRgTuecRU8hqY130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605856.RA31dJfP-FGriBpQuEyger-YYd7h4-BddRgTuecRU8hqY130_provenance.
• NP606140.RAPHA_FE80VzPIJoQ9I6WPU6AZTIFRyJcxsOHe0c-jySA130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606140.RAPHA_FE80VzPIJoQ9I6WPU6AZTIFRyJcxsOHe0c-jySA130_provenance.
• NP873300.RAMWyLvBUVNoiy27Qjr4ey9uyJ7zngWCIyFPwTJLp_Eoo130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873300.RAMWyLvBUVNoiy27Qjr4ey9uyJ7zngWCIyFPwTJLp_Eoo130_provenance.
• NP873317.RAFRsDrSPXJBF2TRgq_kkVtlbCovMf5fsvJqtYt0MFDhA130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873317.RAFRsDrSPXJBF2TRgq_kkVtlbCovMf5fsvJqtYt0MFDhA130_provenance.
• NP978394.RAO0qBk9LqqnDpPz6IKbCDv1uAHn8D9Dp03ujS1AnGDoY130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978394.RAO0qBk9LqqnDpPz6IKbCDv1uAHn8D9Dp03ujS1AnGDoY130_provenance.
• NP978675.RAH9-SpYZIOHlXj9wU7-M1q-f7ZFc1nkA31csgYUNrNtc130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978675.RAH9-SpYZIOHlXj9wU7-M1q-f7ZFc1nkA31csgYUNrNtc130_provenance.
• NP781585.RA0GhLoeLdPebUCkXHo9Xt7hM56O6g-Zu4SGwE8N991GU130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781585.RA0GhLoeLdPebUCkXHo9Xt7hM56O6g-Zu4SGwE8N991GU130_provenance.
• NP781617.RAxro5UjgHNSD3l7n8sIdwTRHk0pGC2TF18eGYz5cY04k130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781617.RAxro5UjgHNSD3l7n8sIdwTRHk0pGC2TF18eGYz5cY04k130_provenance.
• NP1314671.RAFU5hPD5SEpMa04DLJ-TPVkDWdUyxlTlvYekniFOE6pg130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314671.RAFU5hPD5SEpMa04DLJ-TPVkDWdUyxlTlvYekniFOE6pg130_provenance.
• NP1314673.RAGhZwbCbRXbqE_Y-Nku_CkAp3RrMIB-X7kVUbQ-Ej0gk130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314673.RAGhZwbCbRXbqE_Y-Nku_CkAp3RrMIB-X7kVUbQ-Ej0gk130_provenance.
• NP1314684.RAK-E5OQrprMUMIvz5dHjKxWPopo1N4D1T-_01X3cQxb8130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314684.RAK-E5OQrprMUMIvz5dHjKxWPopo1N4D1T-_01X3cQxb8130_provenance.
• NP978654.RA9BUwS2UHGEy8-_bsuwfKoK38ZsX9RKO3j-BhtYovJ3U130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978654.RA9BUwS2UHGEy8-_bsuwfKoK38ZsX9RKO3j-BhtYovJ3U130_provenance.
• NP913883.RA01ai7tIMZx4s4YA2tkODqdVnlQ02pCYzvbauAXYjMIA130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913883.RA01ai7tIMZx4s4YA2tkODqdVnlQ02pCYzvbauAXYjMIA130_provenance.
• NP914240.RAxdZgxoBBaQWR3j0KQSzKnV1UOlEFqgLVEDToEdPdW3Y130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914240.RAxdZgxoBBaQWR3j0KQSzKnV1UOlEFqgLVEDToEdPdW3Y130_provenance.
• NP1314665.RA_KKyxOWZCuxApatrKQSCfKUYUKeHNceHbYBFEDnQl18130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314665.RA_KKyxOWZCuxApatrKQSCfKUYUKeHNceHbYBFEDnQl18130_provenance.
• NP1314667.RA5ec_NXz8sAOojF07Al66zDdLyy-V0KCIkj7c-L3Wy0A130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314667.RA5ec_NXz8sAOojF07Al66zDdLyy-V0KCIkj7c-L3Wy0A130_provenance.
• NP1314675.RA4p17sLUlmoFJ6_Gb_QPQI6lv_nmG5_xLOhLVGexEIoE130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314675.RA4p17sLUlmoFJ6_Gb_QPQI6lv_nmG5_xLOhLVGexEIoE130_provenance.
• NP1314676.RA-fIT0kXpUGsFkqavdxJBcAMoTWBSwAWjabSGrHccrk4130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314676.RA-fIT0kXpUGsFkqavdxJBcAMoTWBSwAWjabSGrHccrk4130_provenance.
• NP1314682.RAyU5LFo5-lIM09pYfXResVEBu2V4Cn4_gHoAzaZAjkbs130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314682.RAyU5LFo5-lIM09pYfXResVEBu2V4Cn4_gHoAzaZAjkbs130_provenance.
• NP1314683.RA_kcAJyRuD-BLju-IU7A2-K-jp-c73AGYy_vwElB9b3M130_assertion description "[We conclude that the 5q-syndrome may be best defined as primary MDS of the FAB type RA with a 5q deletion as the sole karyotypic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1314683.RA_kcAJyRuD-BLju-IU7A2-K-jp-c73AGYy_vwElB9b3M130_provenance.